APLSApellis Pharmaceuticals, Inc.

$2B

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$128M

Operating Income

-$128M

Net Income

-$128M

EPS (Diluted)

$-2.34

Cash Flow

Operating Cash Flow

-$131M

Free Cash Flow

-$131M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$204M

Total Liabilities

$43M

Stockholders' Equity

$161M

Cash & Equivalents

$176M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$128M	-$51M	-152.0%
Operating Income	-$128M	-$51M	-152.0%
Net Income	-$128M	-$51M	-150.0%

APLS FY 2018 Earnings — Apellis Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena